Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1452-1457

  Chen, Yen Hsu ^a   Lu, Po Liang ^a   Huang, Cheng Hua ^b   Liao, Chun Hsing ^c   Lu, Chin Te ^d   Chuang, Yin Ching ^e   Tsao, Shih Ming ^f   Chen, Yao Shen ^g,h   Liu, Yung Ching ^g,h   Chen, Wei Yu ⁱ   Jang, Tsrang Neng ⁱ   Lin, Hsiu Chen ^j   Chen, Chih Ming ^k   Shi, Zhi Yuan ^l   Pan, Sung Ching ^m   Yang, Jia Ling ^m   Kung, Hsiang Chi ^m   Liu, Chun Eng ⁿ   Cheng, Yu Jen ⁿ   Liu, Jien Wei ^o   Sun, Wu ^p   Wang, Lih Shinn ^q   Ko, Wen Chien ^r   Yu, Kwok Woon ^s   Chiang, Ping Cherng ^t   Lee, Ming Hsun ^t   Lee, Chun Ming ^u   Hsu, Gwo Jong ^v   Hsueh, Po Ren ^m   more..

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d LOTUNG POH AI HOSPITAL   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^j TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^k TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^l TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^m NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

ⁿ CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^o CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^p Pao Chien Hospital   (Taiwan)

^q BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^r NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^s TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^t Chang Gung Medical Foundation Linkou Branch   (Taiwan)

^u MACKAY MEMORIAL HOSPITAL   (Taiwan)

^v CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANT STREPTOCOCCUS PNEUMONIAE; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; TAIWAN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; KLEBSIELLA PNEUMONIAE; LONGITUDINAL STUDIES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TAIWAN; VANCOMYCIN;

EID: 84863116394     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06053-11     Document Type: Article

References (21)

1. Boucher HW, et al. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12.
2. Bouchillon SK, Iredell JR, Barkham T, Lee K, Dowzicky MJ. 2009. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Int. J. Antimicrob. Agents 33:130-136.
3. Cai Y, Wang R, Liang B, Bai N, Liu Y. 2011. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease. Antimicrob. Agents Chemother. 55:1162-1172.
4. Chen YH, et al. 2011. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J. Infect. 62:280-291.
5. Chen WY, Jang TN, Huang CH, Hsueh PR. 2009. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006. J. Microbiol. Immunol. Infect. 42:317-323.
6. Clinical and Laboratory Standards Institute. 2011. Performance standard for antimicrobial susceptibility testing (M100-S20). CLSI, Wayne, PA.
7. Cosgrove SE. 2006. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis. 42(Suppl. 2):S82-S89. (Pubitemid 43054219)
8. Darabi A, Hocquet D, Dowzicky MJ. 2010. Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial. Diagn. Microbiol. Infect. Dis. 67:78-86.
9. Dowzicky MJ, Chmelarova E. 2011. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009. Int. J. Antimicrob. Agents 37:562-566.
10. Farrell DJ, Turnidge JD, Bell J, Sader HSHS, Jones RN. 2010. The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). J. Infect. 60:440-451.
11. Hsueh PR. 2008. Tigecycline In-Vitro Surveillance in Taiwan (TIST). Int. J. Antimicrob. Agents 32(Suppl. 3):S173.
12. Jean SS, Hsueh PR. 2011. High burden of antimicrobial resistance in Asia. Int. J. Antimicrob. Agents 37:291-295.
13. Johnson AP. 2011. Methicillin-resistant Staphylococcus aureus: the European landscape. J. Antimicrob. Chemother. 66(Suppl. 4):iv43-iv48.
14. Jones RN, et al. 2007. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J. Clin. Microbiol. 45:227-230. (Pubitemid 46106432)
15. Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA. 2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J. Antimicrob. Chemother. 61:46-53.
16. Papaparaskevas J, et al. 2010. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn. Microbiol. Infect. Dis. 66:187-194.
17. Ruzin A, Visalli MA, Keeney D, Bradford PA. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 49:1017-1022. (Pubitemid 40327718)
18. Sader HS, Farrell DJ, Jones RN. 2011. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009). Diagn. Microbiol. Infect. Dis. 69:223-227.
19. Silva-Sanchez J, et al. 2011. In vitro activity of tigecycline against extended-spectrum beta-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study. Diagn. Microbiol. Infect. Dis. 70:270-273.
20. Wang YF, Dowzicky MJ. 2010. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia andMICchange during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008. Diagn. Microbiol. Infect. Dis. 68:73-79.
21. Zhanel GG, et al. 2010. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob. Agents Chemother. 54:4684-4693.